ArticleCancer immunology, immunotherapy : CII2025

RERE-AS1 as a regulator of immune modulation and therapeutic response in breast cancer.

Shaohui Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.